SE388613B - Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar med beta-adrenergiska blockeringsegenskaper - Google Patents

Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar med beta-adrenergiska blockeringsegenskaper

Info

Publication number
SE388613B
SE388613B SE7213230A SE1323072A SE388613B SE 388613 B SE388613 B SE 388613B SE 7213230 A SE7213230 A SE 7213230A SE 1323072 A SE1323072 A SE 1323072A SE 388613 B SE388613 B SE 388613B
Authority
SE
Sweden
Prior art keywords
preparation
alkyl
beta
blocking properties
adrenergic blocking
Prior art date
Application number
SE7213230A
Other languages
English (en)
Swedish (sv)
Inventor
L M Weinstock
R J Tull
D M Mulvey
B K Wasson
Original Assignee
Frosst & Co Charles E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frosst & Co Charles E filed Critical Frosst & Co Charles E
Priority claimed from US00370994A external-priority patent/US3812182A/en
Priority claimed from US05/417,301 external-priority patent/US3962338A/en
Priority claimed from US425912A external-priority patent/US3892744A/en
Publication of SE388613B publication Critical patent/SE388613B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7213230A 1968-05-22 1969-05-21 Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar med beta-adrenergiska blockeringsegenskaper SE388613B (sv)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US73133368A 1968-05-22 1968-05-22
US81847469A 1969-04-21 1969-04-21
US81808669A 1969-04-21 1969-04-21
US81809069A 1969-04-21 1969-04-21
US17223071A 1971-08-16 1971-08-16
US17223271A 1971-08-16 1971-08-16
US17223171A 1971-08-16 1971-08-16
US17914771A 1971-09-09 1971-09-09
US17914571A 1971-09-09 1971-09-09
US28401372A 1972-08-25 1972-08-25
US00370994A US3812182A (en) 1968-05-22 1973-06-18 S-bis-(2-lower alkyl amino hydroxy-methylethoxy)-methanes
US05/417,301 US3962338A (en) 1968-05-22 1973-11-19 Novel methods and compounds employed therein
US425912A US3892744A (en) 1968-05-22 1973-12-18 Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles

Publications (1)

Publication Number Publication Date
SE388613B true SE388613B (sv) 1976-10-11

Family

ID=27584550

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7213230A SE388613B (sv) 1968-05-22 1969-05-21 Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar med beta-adrenergiska blockeringsegenskaper
SE7410837A SE421001B (sv) 1968-05-22 1974-08-27 Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar och forfarande for framstellning av denna

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7410837A SE421001B (sv) 1968-05-22 1974-08-27 Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar och forfarande for framstellning av denna

Country Status (10)

Country Link
US (3) US3657237A (xx)
AT (3) AT305229B (xx)
BE (1) BE733387A (xx)
CA (1) CA949069A (xx)
CH (5) CH544119A (xx)
DE (1) DE1925955A1 (xx)
FR (2) FR2039306B1 (xx)
GB (2) GB1267328A (xx)
NL (1) NL153189B (xx)
SE (2) SE388613B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892744A (en) * 1968-05-22 1975-07-01 Merck & Co Inc Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles
JPS4913176A (xx) * 1972-06-03 1974-02-05
US3891639A (en) * 1973-04-19 1975-06-24 Merck Sharp & Dohme 4-{8 3-Amino-2-acyloxypropoxy{9 -1,2,5-thiadiazole compounds
US4011217A (en) * 1973-04-19 1977-03-08 Merck Sharp & Dohme (I.A.) Corporation 4-(3-amino-2-acyloxypropoxy)-1,2,5-thiadiazole compounds
AU509371B2 (en) * 1975-08-07 1980-05-08 F. Hoffmann-La Roche Ag Diazepine Derivatives
US4097490A (en) * 1975-09-25 1978-06-27 Merck & Co., Inc. Pyroglutamic acid salts of t-butylamino-2,3-dihydroxypropane
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
ZA805250B (en) * 1979-09-04 1981-09-30 Bristol Myers Co Chemical compounds
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4550117A (en) * 1982-07-26 1985-10-29 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines, derivatives thereof, having anti-hypertensive activity
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
US5320839A (en) * 1991-10-11 1994-06-14 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
US5523301A (en) * 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
TWI293087B (en) * 2003-02-05 2008-02-01 Hitachi Chemical Co Ltd Friction material composition and friction material using thereof
US7090548B1 (en) * 2005-02-03 2006-08-15 International Business Machines Corporation Method of using a linear propulsor array for propulsion and navigation
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (en) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2964530A (en) * 1958-05-02 1960-12-13 Sterling Drug Inc 3-alkyl-4-hydroxymethyl-4-alkyloxazolidines

Also Published As

Publication number Publication date
DE1925955A1 (de) 1970-10-29
GB1264558A (xx) 1972-02-23
NL6907872A (xx) 1969-11-25
AT305229B (de) 1973-02-12
US3781284A (en) 1973-12-25
CH543478A (de) 1973-12-14
BE733387A (xx) 1969-11-21
FR2039306B1 (xx) 1974-03-22
US3657237A (en) 1972-04-18
SE7410837L (xx) 1974-08-27
US3766180A (en) 1973-10-16
CH553214A (de) 1974-08-30
FR2039306A1 (xx) 1971-01-15
CH544119A (de) 1973-12-28
FR2116583A1 (xx) 1972-07-13
CH554887A (de) 1974-10-15
NL153189B (nl) 1977-05-16
GB1267328A (en) 1972-03-15
CH560710A5 (xx) 1975-04-15
SE421001B (sv) 1981-11-16
AT294830B (de) 1971-12-10
AT289788B (de) 1971-05-10
FR2116583B1 (xx) 1982-03-19
CA949069A (en) 1974-06-11

Similar Documents

Publication Publication Date Title
SE388613B (sv) Mellanprodukt till anvendning for framstellning av 1,2,5-tiadiazolforeningar med beta-adrenergiska blockeringsegenskaper
GB1496872A (en) Da forfarande for framstellning av karbostyrol- eller 3,4-dihydrokarbosty
GB1435139A (en) Thiazole derivatives
ES448646A1 (es) Procedimiento para preparar bencenosulfonamidas sustituidas en n.
ES442845A2 (es) Procedimiento para la preparacion de nuevos derivados de la n-(trimetoxi-3,4,5 cinnamoil)piperazina.
GB1490015A (en) Therapeutic guanidine derivatives
GB1342558A (en) Substituted 3-benzylpyridines
GB1239029A (xx)
GB1424450A (en) Isoindoline intermediates
GB1436226A (en) Heterocyclic fused-ring derivatives of tetrahydronaphthalene and related compounds
ES227095A1 (es) UN MÉTODO DE PREPARACIoN DE 1,3,4-TIADIAZOL-5-SULFONAMIDAS 2-(N-ACIL-N-AMINO) SUSTITUiDAS.
GB1079467A (en) N-(4-amino-2-butynyl) cyclicimides
ES420537A1 (es) Procedimiento para la produccion de ureas de (3-benzo-1,2,4-triacinil-dioxido (1,4).
GB1014919A (en) Acetamide derivatives and process for their preparation
GB1352464A (en) N-alkyl-alpha-3,5-substituted phenoxy-alkyl amides and their use as herbicides
GB983662A (en) Diazotype material
GB1198605A (en) Organic Disulphides
GB1457255A (en) 1-phenoxy-2-hydroxy-3-2-amido-chromonyloxy-propanes
GB1242112A (en) 3-pyrazolidinimine derivatives
GB1106865A (en) Light-sensitive piperazinyl-benzene diazonium salts
GB1381425A (en) N-phenyl-piperazine derivatives
GB1219388A (en) Preparation of pyrazinoylguanidines
ES375527A1 (es) Un procedimiento para la preparacion de compuestos amino- carbonilalquilicos n-sustituidos o n,n-disustituidos.
GB1428269A (en) Pyrimidino-triazine compounds and their use as pesticides
GB1351922A (en) Nitrofuryl-triazolo-pyridazine derivatives